ABSTRACT

Multiple sclerosis (MS) is a chronic infl ammatory disease of the central nervous system (CNS). It is characterized by a breakdown of the myelin sheath, the protective layer surrounding the axons, with consequent interruption of the salutatory conduction of the axon potential. The progressive accumulation of chronic lesions results in a progressive clinical course, associated with varying degrees of axonal pathology and progressive neurological dysfunction.